AVO Aveon Group LP Com USD0.01

Advanced Medical Optics Announces Analyst Day Event and Live Webcast; Event to be Held June 9 in New York City SANTA ANA, Calif., June 2 /PRNewswire-FirstCall/ -- Advanced Medical Optics, Inc. (AMO) (NYSE:AVO), a global leader in ophthalmic surgical devices and eye care products, will host an Analyst Day on June 9, 2005, in New York City. (Logo: http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO ) Management presentations will begin at 8:30 a.m. (EDT) and will include an overview of the company, discussions of AMO's growth strategy and refractive opportunity, and a review of financial performance and guidance. AMO presenters will include James V. Mazzo, president and chief executive officer; C. Russell Trenary III, corporate vice president and chief marketing officer; Jane E. Rady, corporate vice president, strategy and technology; and Richard A. Meier, executive vice president, operations and finance and chief financial officer. Guest speakers will include Kerry Assil, M.D., Assil Eye Institute; Eric Donnenfeld, M.D., Ophthalmic Consultants of Long Island and New York University; Marc Odrich, M.D, Columbia University; and Jim Thimons, O.D., TLC Connecticut and The New England College of Optometry. To access the live web conference, please dial (877) 272-5895 (participant code 6133687) and visit the company's Investors site at http://www.amo-inc.com/. Replay will also be available on demand from the website at the conclusion of the program and will run through June 16, 2005. About Advanced Medical Optics (AMO) Advanced Medical Optics (NYSE:AVO) is a global medical device leader focused on the discovery and delivery of innovative vision technologies that optimize the quality of life for people of all ages. Products in the ophthalmic surgical line include intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastics, microkeratomes, glaucoma implants and related products used in cataract and refractive surgery. AMO owns or has the rights to such ophthalmic surgical product brands as ReZoom(TM), Phacoflex(R), Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM) intraocular lenses, STAR S4(TM) laser vision correction system, WaveScan Wavefront(R) system, and CustomVue(R) procedure, Sovereign(R) and Sovereign(R) Compact(TM) phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) and Amadeus(TM) II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the Baerveldt(R) glaucoma shunt. Products in the contact lens care line include disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting drops. Among the contact lens care product brands the company possesses are COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F, Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R) and blink(TM) branded products. Amadeus is a licensed product of, and a trademark of, SIS, Ltd. AMO is based in Santa Ana, California, and employs approximately 3,500 worldwide. The company has operations in about 20 countries and markets products in approximately 60 countries. For more information, visit the company's Web site at http://www.amo-inc.com/. Investor Contact: Erika Richmond (714) 247-8348 http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO http://photoarchive.ap.org/ DATASOURCE: Advanced Medical Optics, Inc. CONTACT: investors, Erika Richmond of Advanced Medical Optics, Inc., +1-714-247-8348, Web site: http://www.amo-inc.com/

Copyright